Lyka Labs enters into out-licensing deal with US based Generics Company

30 May 2017 Evaluate

Lyka Labs has entered into out-licensing / technology transfer deal with a US based Generics Company. It has entered an out-licensing / technology transfer deal for a basket of 12 Sterile Injectable Formulations for Manufacturing, Sales & Distribution in the United State of America.

The market size of the licensed formulations is approximately $ 1.4 billion, as per IMS MAT March 2017. The company will be eligible for a royalty on end sales. Going forward, the company will continue to explore opportunities to monetize its R&D capabilities in the regulated markets throughout-licensing partnerships.

Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.


Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×